Swiss drugmaker Vifor had bid interest but talks halted

Swiss drugmaker Vifor had bid interest but talks halted

Swiss drugmaker Vifor Pharma had a recent takeover approach from at least one private equity firm, but talks were halted due to differences over price, two sources familiar with the situation said. The financial investors behind the initial approach suspended the...
Pictet unveils debut tech-themed private equity fund

Pictet unveils debut tech-themed private equity fund

Pictet Alternative Advisors, part of Geneva-based private bank Pictet Group, has launched its first tech-focused fund, a $300m private equity vehicle. The new strategy, Pictet Thematic Private Equity – Technology, will target funds of all sizes and companies from...